Combined ARHGEF6 and Tumor Mutational Burden may serve as a potential biomarker for immunotherapy of lung adenocarcinoma
ARHGEF6, a member of the Dbl-related guanylate exchanger (GEF) family, is highly expressed in gastric cancer and glioma. However, scientists still do not know whether it plays a pivotal role in the pathogenesis of lung adenocarcinoma（LUAD）. The prognostic significance of ARHGEF6 expression was asses...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2023-08-01
|
| シリーズ: | Heliyon |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2405844023057092 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|